Pantoprazole sodium and Xylometazoline hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Pantoprazole sodium (pantoprazole sodium) and Xylometazoline hydrochloride (xylometazoline hydrochloride). Common drug interactions include fatigue among females and carbuncle among males.

The phase IV clinical study analyzes what interactions people have when they take Pantoprazole sodium and Xylometazoline hydrochloride. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Pantoprazole sodium?

Pantoprazole sodium has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 66,891 Pantoprazole sodium users. Check the latest studies of Pantoprazole sodium.

What is Xylometazoline hydrochloride?

Xylometazoline hydrochloride has active ingredients of xylometazoline hydrochloride. It is often used in nasal congestion. eHealthMe is studying from 808 Xylometazoline hydrochloride users. Check the latest studies of Xylometazoline hydrochloride.



On Jul, 12, 2026

31 people who take Pantoprazole sodium and Xylometazoline hydrochloride together, and have interactions are studied.

Pantoprazole sodium and Xylometazoline hydrochloride drug interactions.

What are the common drug interactions of Pantoprazole Sodium and Xylometazoline Hydrochloride, by gender? *:

female:

  1. Fatigue (feeling of tiredness)
  2. Alopecia (absence of hair from areas of the body)
  3. Sinusitis (inflammation of sinus)
  4. Abdominal distension
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  7. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  8. Anaemia (lack of blood)
  9. Arthralgia (joint pain)
  10. Cystitis (inflammation of the wall of the bladder)

male:

  1. Carbuncle (a carbuncle is an abscess larger than a boil)
  2. Erythema (redness of the skin)
  3. Skin lesion
  4. Dyspnoea (difficult or laboured respiration)
  5. Neutropenia (an abnormally low number of neutrophils)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Stenotrophomonas sepsis (blood infection by stenotrophomonas)
  8. Thrombocytopenia (decrease of platelets in blood)
  9. Prothrombin time shortened
  10. Anaemia (lack of blood)

What are the common drug interactions of Pantoprazole Sodium and Xylometazoline Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  3. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)

40-49:

  1. Pyelonephritis (inflammation of kidney caused by bacteria)

50-59:

n/a

60+:

  1. Fatigue (feeling of tiredness)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Stenotrophomonas sepsis (blood infection by stenotrophomonas)
  4. Arthralgia (joint pain)
  5. Cystitis (inflammation of the wall of the bladder)
  6. Dyspnoea exertional (breathlessness or shortness of breath)
  7. Ear infection
  8. Fracture
  9. Fungal infection
  10. Haemorrhage (bleeding)

What are the existing conditions these people have? *

  1. High Blood Pressure: 10 people, 32.26%
  2. Constipation: 9 people, 29.03%
  3. Immunodeficiency Common Variable: 6 people, 19.35%
  4. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 6 people, 19.35%
  5. Nasopharyngitis (inflammation of the nasopharynx): 6 people, 19.35%
  6. Upper Respiratory Tract Infection: 5 people, 16.13%
  7. Nausea (feeling of having an urge to vomit): 5 people, 16.13%
  8. Cough: 5 people, 16.13%
  9. Pain: 5 people, 16.13%
  10. Muscle Spasms (muscle contraction): 5 people, 16.13%

* Approximation only. Some reports may have incomplete information.

Do you take Pantoprazole sodium and Xylometazoline hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Pantoprazole sodium and Xylometazoline hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Pantoprazole sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Xylometazoline hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pantoprazole sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Xylometazoline hydrochloride and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on pantoprazole sodium and xylometazoline hydrochloride (the active ingredients of Pantoprazole sodium and Xylometazoline hydrochloride, respectively), and Pantoprazole sodium and Xylometazoline hydrochloride (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: